Positive multifocal PSMA PET/CT in a patient with prostate cancer and follicular lymphoma
Prostate-specific membrane antigen (PSMA) PET/CT is a highly reliable nuclear tracer for diagnostic imaging of prostate cancer. However, PSMA is also expressed by some nonprostatic tissues such as benign tumors, inflammatory processes, and malignant neoplasms. This case presents a patient with prost...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
January 2022
|
| In: |
Clinical nuclear medicine
Year: 2022, Volume: 47, Issue: 1, Pages: e47-e48 |
| ISSN: | 1536-0229 |
| DOI: | 10.1097/RLU.0000000000003828 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/RLU.0000000000003828 Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/nuclearmed/Abstract/2022/01000/Positive_Multifocal_PSMA_PET_CT_in_a_Patient_With.44.aspx 
|
| Author Notes: | Katharina Dendl, Andreas Merkel, Clemens Kratochwil, Peter L. Choyke, Christian Kleist, Jens Cardinale, Uwe Haberkorn, Frederik L. Giesel |
| Summary: | Prostate-specific membrane antigen (PSMA) PET/CT is a highly reliable nuclear tracer for diagnostic imaging of prostate cancer. However, PSMA is also expressed by some nonprostatic tissues such as benign tumors, inflammatory processes, and malignant neoplasms. This case presents a patient with prostate cancer and follicular lymphoma undergoing PSMA PET/CT. Remarkably, both tumor entities were clearly detected in the scan. Yet, the 2 malignancies demonstrated rather different ranges in terms of SUVmax uptake values and therefore still enabled precise and accurate discrimination of prostate cancer and follicular lymphoma. |
|---|---|
| Item Description: | Gesehen am 19.01.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1536-0229 |
| DOI: | 10.1097/RLU.0000000000003828 |